MetLife Investment Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-33,319
| Closed | -$5.04M | – | 2888 |
|
|
2022
Q3 | $5.04M | Buy |
33,319
+985
| +3% | +$149K | 0.04% | 402 |
|
|
2022
Q2 | $4.71M | Buy |
32,334
+2,495
| +8% | +$364K | 0.04% | 454 |
|
|
2022
Q1 | $3.54M | Buy |
29,839
+10,558
| +55% | +$1.25M | 0.02% | 732 |
|
|
2021
Q4 | $2.66M | Hold |
19,281
| – | – | 0.02% | 737 |
|
|
2021
Q3 | $2.68M | Hold |
19,281
| – | – | 0.02% | 710 |
|
|
2021
Q2 | $1.87M | Buy |
19,281
+1,065
| +6% | +$103K | 0.02% | 905 |
|
|
2021
Q1 | $1.25M | Sell |
18,216
-1,475
| -7% | -$101K | 0.01% | 1047 |
|
|
2020
Q4 | $1.69M | Sell |
19,691
-1,125
| -5% | -$96.4K | 0.02% | 908 |
|
|
2020
Q3 | $1.35M | Hold |
20,816
| – | – | 0.01% | 895 |
|
|
2020
Q2 | $1.52M | Buy |
20,816
+2,407
| +13% | +$176K | 0.02% | 842 |
|
|
2020
Q1 | $626K | Buy |
18,409
+1,060
| +6% | +$36.1K | 0.01% | 1096 |
|
|
2019
Q4 | $944K | Hold |
17,349
| – | – | 0.01% | 1128 |
|
|
2019
Q3 | $724K | Buy |
17,349
+3,381
| +24% | +$141K | 0.01% | 1221 |
|
|
2019
Q2 | $612K | Hold |
13,968
| – | – | 0.01% | 1367 |
|
|
2019
Q1 | $719K | Buy |
13,968
+1,801
| +15% | +$92.7K | 0.01% | 1233 |
|
|
2018
Q4 | $450K | Hold |
12,167
| – | – | 0.01% | 1431 |
|
|
2018
Q3 | $457K | Buy |
+12,167
| New | +$457K | ﹤0.01% | 1592 |
|